nach oben

Erschienen in:

02.06.2023 | Original Article

Effect of ethyl gallate and propyl gallate on dextran sulfate sodium (DSS)-induced ulcerative colitis in C57BL/6 J mice: preventive and protective

verfasst von: Priyanka Raju Chougule, Rajendra Sangaraju, Pradeep B. Patil, S. S. Y. H. Qadri, Virendra V. Panpatil, Sudip Ghosh, Sathish Kumar Mungamuri, Manjula Bhanoori, Sukesh Narayan Sinha

Erschienen in: Inflammopharmacology | Ausgabe 4/2023

Einloggen, um Zugang zu erhalten

Abstract

Objective and design

Inflammatory bowel disease (IBD) is an idiopathic inflammatory condition of the digestive system marked by oxidative stress, leukocyte infiltration, and elevation of inflammatory mediators. In this study, we demonstrate the protective effect of ethyl gallate (EG), a phytochemical, and propyl gallate (PG), an anti-oxidant, given through normal drinking water (DW) and copper water (CW) in various combinations, which had a positive effect on the amelioration of DSS-induced ulcerative colitis in C57BL/6 J mice.

Materials and methods

We successfully determined the levels of proinflammatory cytokines and anti-oxidant enzymes by ELISA, tracked oxidative/nitrosative stress (RO/NS) by in vivo imaging (IVIS) using L-012 chemiluminescent probe, disease activity index (DAI), and histopathological and morphometric analysis of colon in DSS-induced colitis in a model.

Results

The results revealed that oral administration of ethyl gallate and propyl gallate at a dose of 50 mg/kg considerably reduced the severity of colitis and improved both macroscopic and microscopic clinical symptoms. The level of proinflammatory cytokines (TNF-α, IL-6, IL-1β, and IFN-γ) in colonic tissue was considerably reduced in the DSS + EG-treated and DSS + PG-treated groups, compared to the DSS alone-treated group. IVIS imaging of animals from the DSS + EG and DSS + PG-treated groups showed a highly significant decrease in RO/NS species relative to the DSS control group, with the exception of the DSS + PG/CW and DSS + EG + PG/CW-treated groups. We also observed lower levels of myeloperoxidase (MPO), nitric oxide (NO), and lipid peroxidation (LPO), and restored levels of GST and superoxide dismutase (SOD) in DSS + EG-DW/CW, DSS + PG/DW, and DSS + EG + PG/DW groups compared to DSS alone-treated group. In addition, we showed that the EG, PG, and EG + PG treatment significantly reduced the DAI score, and counteracted the body weight loss and colon shortening in mice compared to DSS alone-treated group. In this 21-day study, mice were treated daily with test substances and were challenged to DSS from day-8 to 14.

Conclusion

Our study highlights the protective effect of ethyl gallate and propyl gallate in various combinations which, in pre-clinical animals, serve as an anti-inflammatory drug against the severe form of colitis, indicating its potential for the treatment of IBD in humans. In addition, propyl gallate was investigated for the first time in this study for its anti-colitogenic effect with normal drinking water and reduced effect with copper water.

Graphical Abstract

Abdelmegid MA, Abdo FK, Ahmed FE, Kattaia AAJS (2019) Therapeutic effect of gold nanoparticles on DSS-induced ulcerative colitis in mice with reference to interleukin-17 expression. Sci Rep 9:1–16

Abhirami NR, Laksmi VV, Deepitha AM (2022) A review on prevalence of inflammatory bowel disease in India. J Drug Deliv Therapeutics 12(6):219–223

Ahn D, Kim J, Nam G, Zhao X, Kwon J, Hwang JY, Kim JK, Yoon SY, Chung SJ (2022) Ethyl gallate dual-targeting PTPN6 and PPARγ shows anti-diabetic and anti-obese effects. Int J Mol Sci 23(9):5020 PubMedPubMedCentral

Alavala S, Sangaraju R, Nalban N, SAHU BD, JERALD MK, KILARI EK, SISTLA R. (2019) Stevioside, a diterpenoid glycoside, shows anti-inflammatory property against dextran sulphate sodium-induced ulcerative colitis in mice. European J Pharmacol 855:192–201

Asghar MN, Emani R, Alam C, Helenius TO, Grönroos TJ, Sareila O, Din MU, Holmdahl R, Hänninen A, Toivola DM (2014) In vivo imaging of reactive oxygen and nitrogen species in murine colitis. Inflamm Bowel Dis 20(8):1435–1447 PubMed

Axelrad JE, Lichtiger S, Yajnik V (2016) Inflammatory bowel disease and cancer: the role of inflammation, immunosuppression, and cancer treatment. World J Gastroenterol 22:4794 PubMedPubMedCentral

Axelsson LG, Landström E, Bylund-Fellenius AC (1998) Experimental colitis induced by dextran sulphate sodium in mice: beneficial effects of sulphasalazine and olsalazine. Aliment Pharmacol Therapeutics 12(9):925–934

Benoit C, Jesse D, Madhu M, Matam VJCPI (2014) Dextran sulfate sodium (DSS)-induced colitis in mice. Current Protocols Immunol 25:1–15

Chen C-H, Liu T-Z, Chen C-H, Wong CH, Chen C-H, Fung-Jou Lu, Chen SC (2007) The efficacy of protective effects of tannic acid, gallic acid, ellagic acid, and propyl gallate against hydrogen peroxide-induced oxidative stress and DNA damages in IMR-90 cells. Mol Nutr Food Res 51:962–968 PubMed

COSKUN M (2014) Intestinal epithelium in inflammatory bowel disease. Front Med 1:24

Cui H, Yuan J, Du X, Wang M, Yue L, Liu J (2015) Ethyl gallate suppresses proliferation and invasion in human breast cancer cells via Akt-NF-κB signaling. Oncol Reports 33(3):1284–1290

de Mattos B, Garcia M, Nogueira JB, Paiatto LN, Albuquerque CG, Souza CL, Fernandes L, Tamashiro W, Simioni PUJMI (2015) Inflammatory bowel disease: an overview of immune mechanisms and biological treatments. Mediators Inflamm 493012:2015

Gancarcikova S, Lauko S, Hrckova G, Andrejcakova Z, Hajduckova V, Madar M, Fecskeova LK, Mudronova D, Mravcova K, Strkolcova G, Nemcova R, Kacirova J, Staskova A, Vilcek S, Bomba A (2020) Innovative animal model of DSS-induced ulcerative colitis in pseudo germ-free mice. Cell 9:2571

Gaudio E, Taddei G, Vetuschi A, Sfera R, Visconti S, Ricciardi G, Caprilli R (1999) Dextran sulfate sodium (DSS) colitis in rats (clinical, structural, and ultrastructural aspects). Gastroenterology 44:1458–1475

Hsu HC, Lin WC, Chang PJ, Hong CZ, Chen CHJE, Medicine T (2013) Propyl gallate inhibits TPA-induced inflammation via the nuclear factor-κB pathway in human THP-1 monocytes. Exp Therapeutic Med 5:964–968

Jacobi H, Eicke B, Witte I (1998) DNA strand break induction and enhanced cytotoxicity of propyl gallate in the presence of copper (II). Free Radical Biol Med 24(6):972–978

Jacobi H, Hinrichsen ML, Weß D, Witte I (1999) Induction of lipid peroxidation in human fibroblasts by the antioxidant propyl gallate in combination with copper (II). Toxicology Lett 110(3):183–190

Jung HJ, Kim SJ, Jeon WK, Kim BC, Ahn K, Kim K, Kim YM, Park EH, Lim CJ (2011) Anti-inflammatory activity of n-propyl gallate through down-regulation of NF-κB and JNK pathways. Inflammation 34:352–361 PubMed

Kalaivani T, Rajasekaran C, Mathew L (2011) Free radical scavenging, cytotoxic, and hemolytic activities of an active antioxidant compound ethyl gallate from leaves of Acacia nilotica (L) Wild Ex Delile subsp indica (Benth) Brenan. J Food Sci 76:T144–T149 PubMed

Karin M (2009) NF-κB as a critical link between inflammation and cancer. Cold Spring Harbor Perspect Biol 1(5):a000141

Kaser A, Zeissig S, Blumberg RSJDD (2010) Genes and environment: how will our concepts on the pathophysiology of IBD develop in the future? Dig Dis 28:395–405 PubMedPubMedCentral

Krishna CM, Kolla JN, Asha S, Reddy TSK (2020) In vitro anti-HIV-1 activity of ethyl gallate. Virus Dis 31:22–27

Macdonald T, Monteleone G, Pender SL (2000) Recent developments in the immunology of inflammatory bowel disease. Scandinavian J Immunol 51:2–9

Mallo N, Lamas J, Leiro JM (2014) Alternative oxidase inhibitors as antiparasitic agents against scuticociliatosis. Parasitology 141(10):1311–1321 PubMed

Maloy KJ, Powrie F (2011) Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature 474(7351):298–306 PubMed

Matricon J (2010) Immunopathogenèse des maladies inflammatoires chroniques de l’intestin. Méd Sci 26(4):405–410

Mehla K, Balwani S, Agrawal A, Ghosh B (2013) Ethyl gallate attenuates acute lung injury through Nrf2 signaling. Biochimie 95(12):2404–2414 PubMed

Mink SN, Jacobs H, Gotes J, Kasian K, Cheng Z-Q (2011) Ethyl gallate, a scavenger of hydrogen peroxide that inhibits lysozyme-induced hydrogen peroxide signaling in vitro, reverses hypotension in canine septic shock. J Appl Physiol 110:359–374 PubMed

Mohan S, Thiagarajan K, Chandrasekaran R (2017) Evaluation of ethyl gallate for its antioxidant and anticancer properties against chemical-induced tongue carcinogenesis in mice. Biochem J 474(17):3011–3025 PubMed

National center for biotechnology information (2023a) PUBCHEM Compound Summary For CID 4947, P. G. R. J., 2023

National center for biotechnology information (2023b) Pubchem compound summary for CID 13250, E. G. R. J., 2023

Ng SC, Shi HY, Hamidi N, Underwood FE, Tang W, Benchimol EI, Panaccione R, Ghosh S, Wu JC, Chan FK, Sung JJ (2017) Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet 390(10114):2769–2778 PubMed

Sahu BD, Tatireddy S, Koneru M, Borkar RM, Kumar JM, Kuncha M, Srinivas R, Sistla R (2014) Naringin ameliorates gentamicin-induced nephrotoxicity and associated mitochondrial dysfunction, apoptosis and inflammation in rats: possible mechanism of nephroprotection. Toxicol Appl Pharmacol 277(1):8–20 PubMed

Sanchez-Muñoz F, Dominguez-Lopez A, Yamamoto-Furusho JK (2008) Role of cytokines in inflammatory bowel disease. World J Gastroenterol 14(27):4280 PubMedPubMedCentral

Sangaraju R, Nalban N, Alavala S, Rajendran V, Jerald MK, Sistla R (2019) Protective effect of galangin against dextran sulfate sodium (DSS)-induced ulcerative colitis in Balb/c mice. Inflamm Res 68:691–704 PubMed

Sangaraju R, Alavala S, Nalban N, Jerald MK, Sistla RJII (2021) Galangin ameliorates Imiquimod-Induced psoriasis-like skin inflammation in BALB/c mice via down regulating NF-κB and activation of Nrf2 signaling pathways. Int Immunopharmacol 96:107754 PubMed

Shen G, Kong AN (2009) Nrf2 plays an important role in coordinated regulation of Phase II drug metabolism enzymes and Phase III drug transporters. Biopharmaceut Drug Dispos 30(7):345–355

Singer II, Kawka DW, Schloemann S, Tessner T, Riehl T, Stenson WF (1998) Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease. Gastroenterology 115(2):297–306 PubMed

Singh R, Chandrashekharappa S, Bodduluri SR, Baby BV, Hegde B, Kotla NG, Hiwale AA, Saiyed T, Patel P, Vijay-Kumar M, Langille MG (2019) Enhancement of the gut barrier integrity by a microbial metabolite through the Nrf2 pathway. Nat Commun 10(1):89 PubMedPubMedCentral

Strober W, Fuss IJ (2011) Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases. Gastroenterology 140(6):1756–1767 PubMed

Sudha VP, Singh KO, Prasad SR, Venkatasubramanian P (2009) Killing of enteric bacteria in drinking water by a copper device for use in the home: laboratory evidence. Trans Royal Soc Tropical Med Hygiene 103(8):819–822

Sudha VP, Sheeba Ganesan GP, Pazhani TR, Nair GB, Venkatasubramanian P (2009) Killing of enteric bacteria in drinking water by a copper device for use in the home: laboratory evidence. Trans Royal Soc Tropical Med Hygiene 103(8):819–822

Tatiya-aphiradee N, Chatuphonprasert W, Jarukamjorn K (2019) Immune response and inflammatory pathway of ulcerative colitis. J Basic Clin Physiol Pharmacol 30:1–10

Tun X, Yasukawa K, Yamada K-I (2014) Involvement of nitric oxide with activation of toll-like receptor 4 signaling in mice with dextran sodium sulfate-induced colitis. Free Radical Biol Med 74:108–117

Viennois E, Chen F, Merlin D (2013) NF-κB pathway in colitis-associated cancers. Trans Gastrointest Cancer 2(1):21

Wang Z, Xue R, Lv M, Qi Y, Wei Yu, Xie Z, Chen W, Wang X, Tian X, Han Bo (2022) Stepwise tracking strategy to screen ingredient from Galla Chinensis based on the “mass spectrometry guided preparative chromatography coupled with systems pharmacology.” J Ethnopharmacol 284:114533 PubMed

Wei PL, Huang CY, Chang YJ (2019) Propyl gallate inhibits hepatocellular carcinoma cell growth through the induction of ROS and the activation of autophagy. PLoS ONE 14(1):e0210513 PubMedPubMedCentral

Wu TW, Fung KP, Zeng LH, Wu J, Nakamura H (1994) Propyl gallate as a hepatoprotector in vitro and in vivo. Biochem Pharmacol 48(2):419–422 PubMed

Xu Y, Pang GR, Lü XF, Chen ZJ, Sun ST, Song JZ (2006) The effect of propyl gallate on the activity of various antifungal drugs against filamentous fungi in vitro. Chin J Ophthalmol 42(4):309–312

Titel: Effect of ethyl gallate and propyl gallate on dextran sulfate sodium (DSS)-induced ulcerative colitis in C57BL/6 J mice: preventive and protective
verfasst von: Priyanka Raju Chougule
Rajendra Sangaraju
Pradeep B. Patil
S. S. Y. H. Qadri
Virendra V. Panpatil
Sudip Ghosh
Sathish Kumar Mungamuri
Manjula Bhanoori
Sukesh Narayan Sinha
Publikationsdatum: 02.06.2023
Verlag: Springer International Publishing
Erschienen in: Inflammopharmacology / Ausgabe 4/2023
Print ISSN: 0925-4692
Elektronische ISSN: 1568-5608
DOI: https://doi.org/10.1007/s10787-023-01254-5

Impuls - Die Nachhaltigkeitsinitiative von Springer Medizin

Springer Medizin

Effect of ethyl gallate and propyl gallate on dextran sulfate sodium (DSS)-induced ulcerative colitis in C57BL/6 J mice: preventive and protective

Abstract

Objective and design

Materials and methods

Results

Conclusion

Graphical Abstract

Impuls - Die Nachhaltigkeitsinitiative von Springer Medizin

Springer Medizin

Abstract

Objective and design

Materials and methods

Results

Conclusion

Graphical Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2023

Kolaviron modulates angiogenesis, apoptosis and inflammatory signaling in rat model of testosterone propionate-induced benign prostate hyperplasia

Pterostilbene attenuates hemin-induced dysregulation of macrophage M2 polarization via Nrf2 activation in experimental hyperglycemia

Neuromodulation in Parkinson’s disease targeting opioid and cannabinoid receptors, understanding the role of NLRP3 pathway: a novel therapeutic approach

The potential effect of metformin on fibroblast growth factor 21 in type 2 diabetes mellitus (T2DM)

Mito-TEMPO mitigates 5-fluorouracil-induced intestinal injury via attenuating mitochondrial oxidative stress, inflammation, and apoptosis: an in vivo study

Ischemic tubular injury: Oxygen-sensitive signals and metabolic reprogramming